₹ 308.75
5.00 (1.65%)
M
Marksans Pharma
₹ 308.75
MARKSANS Financials Summary (Consolidated)
Marksans Pharma revenue increased 10.63% quarter-on-quarter to ₹958 Cr in Sep 2026, while net profit decreased 9.97% quarter-on-quarter to ₹144 Cr. Compared to the same quarter last year, revenue is up 29.15% and net profit is up 44.80%. EPS for the quarter stood at ₹3.12, decreased from ₹3.47 in the previous quarter and up from ₹2.17 a year ago.
Marksans Pharma Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of MARKSANS Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
MARKSANS Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






